ClearPoint Neuro, Inc. (CLPT)
11.16
+0.04
(+0.31%)
USD |
NASDAQ |
May 19, 16:00
11.16
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Research and Development Expense (Quarterly) : 4.522M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 18.69M |
| Stryker Corp. | 404.00M |
| UFP Technologies, Inc. | -- |
| Tandem Diabetes Care, Inc. | 46.04M |
| Abbott Laboratories | 767.00M |